Breaking News

Zealand Pharma A/S ADR (ZEAL)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

Zealand Pharma ADR historical data, for real-time data please try another search

17.59 +0.00 +0.00%

29/09 - Real-time Cboe. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

Volume: 0
Bid/Ask: 8.82 / 20.00
Day's Range: 17.47 - 18.07

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

ZEAL Income Statement

Featured here, the Income Statement (earnings report) for Zealand Pharma A/S ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Annual Quarterly

Advanced Income Statement

Collapse All

Period Ending:

2022

31/12

2022

30/09

2022

30/06

2022

31/03

Total Revenue

23.92

43.71

21.27

15.08

Revenue	23.92	43.71	21.27	15.08
Other Revenue, Total	-	-	-	-

Cost of Revenue, Total

-0.577

0.577

-2.91

2.91

Gross Profit

43.14

24.18

12.16

Total Operating Expenses

259.8

205.79

211.97

240.5

Selling/General/Admin. Expenses, Total	52.57	60.16	60.37	85.16
Research & Development	159.53	145.08	154.38	152.53
Depreciation / Amortization	-7.94	96.73	-	-
Interest Expense (Income) - Net Operating	-19.75	-10.35	-7.52	-18.84
Unusual Expense (Income)	-	-	-	-
Other Operating Expenses, Total	75.97	-86.41	7.65	18.73

Operating Income

-235.88

-162.08

-190.7

-225.42

Interest Income (Expense), Net Non-Operating

133.03

Gain (Loss) on Sale of Assets

2.25

0.054

1.25

-2.38

Other, Net

84.31

-8.47

135.04

-54.08

Net Income Before Taxes

-322.44

-153.66

-326.98

-168.96

Provision for Income Taxes

-1.78

-15.36

12.08

Net Income After Taxes

-151.88

-311.63

-181.04

Minority Interest

Equity In Affiliates

U.S GAAP Adjustment

Net Income Before Extraordinary Items

-151.88

-311.63

-181.04

Total Extraordinary Items

3.54

-176.87

-41.8

Net Income

-148.34

-488.5

-222.84

Total Adjustments to Net Income

21.39

-3.54

176.87

41.8

Income Available to Common Excluding Extraordinary Items

-321.06

-151.88

-311.63

-181.04

Dilution Adjustment

-21.39

3.54

-176.87

-41.8

Diluted Net Income

-321.06

-151.88

-311.63

-181.04

Diluted Weighted Average Shares

51.03

46.28

44.27

43.22

Diluted EPS Excluding Extraordinary Items

-6.29

-3.28

-7.04

-4.19

DPS - Common Stock Primary Issue

Diluted Normalized EPS

-4.18

-2.07

-3.42

-1.31

* In Millions of DKK (except for per share items)

Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

ZEAL Comments

Write your thoughts about Zealand Pharma A/S ADR

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

MIKHAIL KUZNETSOV Jan 30, 2022 7:02AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

It looks good , it 's very interesting , there is a smell of compression of short positions .I feel it will pay us soon , I entered the position at $ 19.28 . It would be a sin not to add this ATM . It seems to me that he will quickly double or even more if he needs a good volume

0 0

Report

Mr Buffett Jun 24, 2019 1:21PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

This company seems to have quite some potential. Figures look very well and phase 3 results for one of their medicines are to be expected next quarter.See attached picture for the trendline of Zealand Pharma since the beginning of this year. The lines indicate the supports and resistances.See picture: https://invst.ly/b3946

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200469720">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="200469720" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200469720" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200469720">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	32,074.5	-30.8	-0.10%
US 500	3,946.7	-2.0	-0.05%
Dow Jones	32,077.09	-28.16	-0.09%
S&P 500	3,946.00	-2.72	-0.07%
Nasdaq	11,758.63	-28.76	-0.24%
S&P 500 VIX	23.13	+0.52	+2.30%
Dollar Index	102.750	+0.543	+0.53%

Crude Oil WTI	69.50	-0.46	-0.66%
Brent Oil	75.25	-0.66	-0.87%
Natural Gas	2.212	+0.058	+2.69%
Gold	1,992.60	-3.30	-0.17%
Silver	23.372	+0.116	+0.50%
Copper	4.0785	-0.0450	-1.09%
US Soybeans	1,426.00	+7.00	+0.49%

U.S. 10Y	3.363	-0.041	-1.20%
U.S. 30Y	3.645	-0.037	-1.01%
U.S. 5Y	3.3819	-0.0350	-1.03%
U.S. 3M	4.6256	-0.0450	-0.97%
US 10Y T-Note	116.27	+0.28	+0.24%
Euro Bund	137.81	+0.40	+0.29%
10-2 Yield Spread	-51.25	+0.00	+0.00%

Apple	159.10	+0.17	+0.11%
Alphabet A	104.97	-0.62	-0.59%
Tesla	189.31	-2.90	-1.51%
Amazon.com	97.63	-1.08	-1.09%
Netflix	327.96	+7.59	+2.37%
Meta Platforms	205.96	+1.68	+0.82%
Bank of America	26.79	-0.18	-0.67%

Recent Quotes

	Name	Price	Chg.	Chg. %
	ZEAL	17.59	+0.00	+0.00%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	189.31	-1.51%	60.04M
AMD	97.96	-2.31%	33.56M
AAPL	159.02	+0.06%	24.77M
NVDA	266.98	-1.81%	23.46M
META	205.83	+0.76%	14.71M
MSFT	279.06	+0.50%	11.82M
NFLX	328.01	+2.39%	8.00M

Name	Last	Chg. %	Vol.
ATVI	83.98	+5.40%	16.47M
SIRI	3.760	+4.16%	7.90M
ISRG	252.66	+3.35%	1.40M
DGX	139.52	+3.05%	554.04K
AEE	82.84	+2.77%	387.55K
PNW	75.98	+2.54%	192.85K
CMS	59.42	+2.52%	401.38K

Name	Last	Chg. %	Vol.
INCY	68.29	-5.49%	1.32M
PDD	73.20	-5.49%	7.16M
MPWR	483.11	-5.37%	198.53K
ENPH	195.08	-4.68%	2.06M
SEDG	278.38	-4.51%	426.60K
DDOG	64.46	-4.42%	2.34M
WBD	13.96	-3.96%	5.48M

Webinars

Where Should You Invest Right Now? Here's Warren Buffett's Advice Wednesday, March 29, 2023 | 10:00AM EDT

The Road Less Travelled in Trading Thursday, April 20, 2023 | 01:00PM EDT